Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 84 | 145 | 115 | 43 | 40 |
| Accounts receivable | -165 | -223 | 37 | -1 | 60 |
| Accounts payable and accrued liabilities | N/A | N/A | 2,320 | 319 | -165 |
| Other Working Capital | 839 | -240 | 2,115 | 430 | 1,408 |
| Other Operating Activity | -17,598 | -10,977 | -22,372 | -9,060 | -7,649 |
| Operating Cash Flow | $-16,841 | $-11,296 | $-17,784 | $-8,269 | $-6,307 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -3 | -21 | -3 | -3 |
| Purchase Sale Intangibles | 59 | -136 | 0 | -42 | N/A |
| Other Investing Activity | 59 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $59 | $-139 | $-21 | $-45 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -101 | -101 | -76 | N/A | N/A |
| Common Stock Issued | 23,012 | 0 | 19,763 | 18,902 | 8,709 |
| Other Financing Activity | -216 | 867 | 2,954 | 712 | -859 |
| Financing Cash Flow | $22,695 | $766 | $22,641 | $19,613 | $7,849 |
| Exchange Rate Effect | -305 | -124 | 687 | 31 | -47 |
| Beginning Cash Position | 11,660 | 22,452 | 16,929 | 5,599 | 4,106 |
| End Cash Position | 17,267 | 11,660 | 22,452 | 16,929 | 5,599 |
| Net Cash Flow | $5,913 | $-10,668 | $4,836 | $11,299 | $1,539 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,841 | -11,296 | -17,784 | -8,269 | -6,307 |
| Capital Expenditure | N/A | -141 | -21 | -45 | -3 |
| Free Cash Flow | -16,841 | -11,437 | -17,805 | -8,314 | -6,310 |